Cargando…

Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo

SIMPLE SUMMARY: Glioblastoma is extremely lethal brain cancer. In our research, we investigated the effect of anti-vimentin nanobody Nb79 on glioblastoma cell invasion. The expression of vimentin in glioma tissues and cells was determined by RT-qPCR. Invasion assay was performed on differentiated gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zottel, Alja, Novak, Metka, Šamec, Neja, Majc, Bernarda, Colja, Sara, Katrašnik, Mojca, Vittori, Miloš, Hrastar, Barbara, Rotter, Ana, Porčnik, Andrej, Lah Turnšek, Tamara, Komel, Radovan, Breznik, Barbara, Jovčevska, Ivana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913279/ https://www.ncbi.nlm.nih.gov/pubmed/36765531 http://dx.doi.org/10.3390/cancers15030573

Ejemplares similares

TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion
por: Porčnik, Andrej, et al.
Publicado: (2021)

Sonication is a suitable method for loading nanobody into glioblastoma small extracellular vesicles
por: Colja, Sara, et al.
Publicado: (2023)

Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
por: Zottel, Alja, et al.
Publicado: (2020)

CCR5-Mediated Signaling is Involved in Invasion of Glioblastoma Cells in Its Microenvironment
por: Novak, Metka, et al.
Publicado: (2020)

Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting
por: Samec, Neja, et al.
Publicado: (2018)

OMRT-11. The effect of microenvironment on glioblastoma stem cells therapeutic resistance
por: Turnsek, Tamara Lah, et al.
Publicado: (2021)

Non-animal glioblastoma models for personalized treatment
por: Zottel, Alja, et al.
Publicado: (2023)

High FREM2 Gene and Protein Expression Are Associated with Favorable Prognosis of IDH-WT Glioblastomas
por: Jovčevska, Ivana, et al.
Publicado: (2019)

Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates
por: Vidak, Marko, et al.
Publicado: (2018)

Coding of Glioblastoma Progression and Therapy Resistance through Long Noncoding RNAs
por: Zottel, Alja, et al.
Publicado: (2020)

Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
por: Šamec, Neja, et al.
Publicado: (2020)

Upregulation of Cathepsin X in Glioblastoma: Interplay with γ-Enolase and the Effects of Selective Cathepsin X Inhibitors
por: Majc, Bernarda, et al.
Publicado: (2022)

The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling
por: Lah, Tamara T., et al.
Publicado: (2022)

TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers
por: Jovčevska, Ivana, et al.
Publicado: (2014)

Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in Glioblastoma Cell Lines and Extracellular Vesicles
por: Zottel, Alja, et al.
Publicado: (2020)

Mesenchymal stem cells differentially affect the invasion of distinct glioblastoma cell lines
por: Breznik, Barbara, et al.
Publicado: (2017)

Current Technologies for RNA-Directed Liquid Diagnostics
por: Martinez-Dominguez, Maria Victoria, et al.
Publicado: (2021)

Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development
por: Majc, Bernarda, et al.
Publicado: (2021)

Bioactive peptides from venoms against glioma progression
por: Majc, Bernarda, et al.
Publicado: (2022)

Nanotechnology Meets Oncology: Nanomaterials in Brain Cancer Research, Diagnosis and Therapy
por: Zottel, Alja, et al.
Publicado: (2019)

Cannabigerol Is a Potential Therapeutic Agent in a Novel Combined Therapy for Glioblastoma
por: Lah, Tamara T., et al.
Publicado: (2021)

Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
por: Jovčevska, Ivana, et al.
Publicado: (2017)

Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma
por: Sorokin, Maxim, et al.
Publicado: (2021)

OligoPrime: An Information System for Oligonucleotide Management
por: Ravnik, Šimen, et al.
Publicado: (2021)

Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas
por: Zolotovskaia, Marianna, et al.
Publicado: (2021)

The Therapeutic Potential of Nanobodies
por: Jovčevska, Ivana, et al.
Publicado: (2019)

Oleic Acid Metabolism via a Conserved Cytochrome P450 System-Mediated ω-Hydroxylation in the Bark Beetle-Associated Fungus Grosmannia clavigera
por: Novak, Metka, et al.
Publicado: (2015)

Infiltrating natural killer cells bind, lyse and increase chemotherapy efficacy in glioblastoma stem-like tumorospheres
por: Breznik, Barbara, et al.
Publicado: (2022)

RECQ1 Helicase Silencing Decreases the Tumour Growth Rate of U87 Glioblastoma Cell Xenografts in Zebrafish Embryos
por: Vittori, Miloš, et al.
Publicado: (2017)

Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast
por: Vogelsang, Matjaz, et al.
Publicado: (2009)

Data in support of association study of the brain-derived neurotrophic factor gene SNPs and completed suicide in the Slovenian sample
por: Ropret, Sandra, et al.
Publicado: (2015)

Localization Patterns of Cathepsins K and X and their Predictive Value in Glioblastoma
por: Breznik, Barbara, et al.
Publicado: (2018)

Imaging of human glioblastoma cells and their interactions with mesenchymal stem cells in the zebrafish (Danio rerio) embryonic brain
por: Vittori, Milos, et al.
Publicado: (2016)

Effects of Mindfulness-Based Therapy on Clinical Symptoms and DNA Methylation in Patients with Polycystic Ovary Syndrome and High Metabolic Risk
por: Dema, Hana, et al.
Publicado: (2023)

Characterization of In Vitro 3D Cell Model Developed from Human Hepatocellular Carcinoma (HepG2) Cell Line
por: Štampar, Martina, et al.
Publicado: (2020)

Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma
por: Ruiz-López, Eduardo, et al.
Publicado: (2022)

Dynamic Intercell Communication between Glioblastoma and Microenvironment through Extracellular Vesicles
por: Krapež, Gloria, et al.
Publicado: (2022)

An Update on Glioblastoma Biology, Genetics, and Current Therapies: Novel Inhibitors of the G Protein-Coupled Receptor CCR5
por: Lah Turnšek, Tamara, et al.
Publicado: (2021)

Active Protein Aggregates Produced in Escherichia coli
por: Peternel, Špela, et al.
Publicado: (2011)

Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells
por: Peternel, Špela, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ga53d0abpu27d43l0el2v7ql5s